Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
MYLAN INC. et al v. APOTEX INC. et al
Case Number:
3:14-cv-04560
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
December 23, 2015
Generic Paxil Flap Ends Without Explanation
Litigation over generic Paxil sales ended Tuesday, when the embroiled drugmakers quietly agreed to drop the New Jersey federal suit accusing GlaxoSmithKline LLC of breaching an exclusivity agreement with Mylan by allowing Apotex to sell generics of the antidepressant in resolving an antitrust dispute.
-
August 28, 2014
Apotex Says Generic Paxil Suit Should Be Tossed
Apotex Inc. asked a New Jersey federal court to throw out a contract suit against it by rival Mylan Inc., claiming the company can't show Apotex acted with malice in continuing to sell generic versions of the antidepressant Paxil that it obtained from GlaxoSmithKline PLC.
-
July 23, 2014
Apotex Blocked From Continuing Generic Paxil Sales
A New Jersey federal judge on Tuesday issued an injunction to block generic-drug manufacturer Apotex Inc. from continuing to sell generic Paxil CR in violation of rival Mylan Inc.'s exclusivity agreement with GlaxoSmithKline PLC, which was barred last week from supplying Apotex with the drug.
-
July 21, 2014
Apotex 'Thumbing Its Nose' At Paxil Bar, Mylan Says
Generic-drug maker Mylan Inc. has alleged that rival Apotex Inc. continues to sell generic Paxil CR in violation of Mylan's exclusivity agreement with GlaxoSmithKline PLC, despite a New Jersey federal judge's order five days ago barring GSK from supplying Apotex with the drug.